Anna Gutridge
Affiliations: | 2017- | Medicinal Chemistry and Molecular Pharmacology | Purdue University, West Lafayette, IN, United States |
Google:
"Anna Gutridge"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hennessy MR, Gutridge AM, French AR, et al. (2023) Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of Medicinal Chemistry |
| French AR, Gutridge AM, Yuan J, et al. (2022) Sex- and β-arrestin-dependent effects of kappa opioid receptor-mediated ethanol consumption. Pharmacology, Biochemistry, and Behavior. 216: 173377 |
| Meqbil YJ, Su H, Cassell RJ, et al. (2021) Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland). 26 |
| Gutridge AM, Chakraborty S, Varga BR, et al. (2021) Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder. Frontiers in Pharmacology. 12: 764885 |
| Chakraborty S, DiBerto JF, Faouzi A, et al. (2021) A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects. Journal of Medicinal Chemistry |
| Ko MJ, Chiang T, Mukadam AA, et al. (2021) β-Arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice. Science Signaling. 14 |
| Sharifi F, Meqbil YJ, Otte A, et al. (2021) Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose. Pharmaceutical Research |
| Creed SM, Gutridge AM, Argade MD, et al. (2020) Isolation and Pharmacological Characterization of Six Opioidergic Alkaloids. Journal of Natural Products |
| Gutridge AM, Robins MT, Cassell RJ, et al. (2019) G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder. British Journal of Pharmacology |